{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:30:09Z","timestamp":1781220609775,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cancergen.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T10:45:59Z","timestamp":1563014759000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation"],"prefix":"10.1016","volume":"238","author":[{"given":"Melissa H.","family":"Cessna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabakaran","family":"Paulraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianoush","family":"Sadre-Bazzaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Szankasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Cluff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay L.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daanish","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reha M.","family":"Toydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cancergen.2019.07.004_bib0001","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2017-04-736421","article-title":"How I treat chronic myelomonocytic leukemia","volume":"130","author":"Solary","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cancergen.2019.07.004_bib0002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<299::AID-GCC11>3.0.CO;2-K","article-title":"BCR\/ABL-negative chronic myeloid leukemia with ETV6\/ABL fusion","volume":"20","author":"Andreasson","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.cancergen.2019.07.004_bib0003","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-4608(02)00609-X","article-title":"Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature","volume":"138","author":"Keung","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.cancergen.2019.07.004_bib0004","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/sj.leu.2403697","article-title":"Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6\/ABL1 fusion transcript","volume":"19","author":"Meyer-Monard","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cancergencyto.2004.06.001","article-title":"Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion","volume":"157","author":"Tirado","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"10.1016\/j.cancergen.2019.07.004_bib0006","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.leukres.2009.03.011","article-title":"Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors","volume":"33","author":"Nand","year":"2009","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.cancergen.2019.07.004_bib0007","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000448984","article-title":"Translocation (9;12)(q34.1;p13.?3) resulted in ETV6-ABL1 fusion in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia","volume":"136","author":"Mori","year":"2016","journal-title":"Acta Haematol"},{"issue":"9","key":"10.1016\/j.cancergen.2019.07.004_bib0008","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood.V99.9.3465","article-title":"Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation","volume":"99","author":"O'Brien","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cancergen.2019.07.004_bib0009","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-013-1975-y","article-title":"Extramedullary T-lymphoid blast crisis of an ETV6\/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2)","volume":"93","author":"Yamamoto","year":"2014","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0010","first-page":"34","article-title":"The novel activation of ABL by fusion to an ets-related gene, TEL","volume":"55","author":"Papadopoulos","year":"1995","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1755-8166-6-39","article-title":"Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review","volume":"6","author":"Gancheva","year":"2013","journal-title":"Mol Cytogenet"},{"issue":"6","key":"10.1016\/j.cancergen.2019.07.004_bib0012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3343\/alm.2014.34.6.475","article-title":"A cryptic ETV6\/ABL1 rearrangement represents a unique fluorescence in situ hybridization signal pattern in a patient with b acute lymphoblastic leukemia","volume":"34","author":"Song","year":"2014","journal-title":"Ann Lab Med"},{"issue":"11","key":"10.1016\/j.cancergen.2019.07.004_bib0013","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2014-04-567057","article-title":"Genetic alterations of the cohesin complex genes in myeloid malignancies","volume":"124","author":"Thota","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cancergen.2019.07.004_bib0014","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood-2013-07-518746","article-title":"Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications","volume":"123","author":"Thol","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cancergen.2019.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ng.2731","article-title":"Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms","volume":"45","author":"Kon","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2019.07.004_bib0016","unstructured":"McGowan-Jordan J., Simons A., Schmid M.An international system for human cytogenetic nomenclature (2016). Karger, Basel."},{"issue":"7571","key":"10.1016\/j.cancergen.2019.07.004_bib0017","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","year":"2015","journal-title":"Nature"},{"issue":"7616","key":"10.1016\/j.cancergen.2019.07.004_bib0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.cancergen.2019.07.004_bib0019","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.cancergen.2019.07.004_bib0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergen.2019.07.004_bib0021","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2017"},{"issue":"9","key":"10.1016\/j.cancergen.2019.07.004_bib0022","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","author":"Zaliova","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-016-0070-7","article-title":"A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature","volume":"4","author":"Tirado","year":"2016","journal-title":"Biomark Res"},{"issue":"3","key":"10.1016\/j.cancergen.2019.07.004_bib0024","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1","article-title":"Molecular cytogenetic and clinical findings in ETV6\/ABL1-positive leukemia","volume":"30","author":"Van Limbergen","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.cancergen.2019.07.004_bib0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","article-title":"ETV6 fusion genes in hematological malignancies: a review","volume":"36","author":"De Braekeleer","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergen.2019.07.004_bib0026","first-page":"50","article-title":"An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: initial response to Imatinib followed by rapid transformation into ALL","volume":"6","author":"Kakadia","year":"2016","journal-title":"Leuk Res Rep"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3343\/alm.2017.37.1.77","article-title":"A case of chronic myeloid leukemia with rare variant ETV6\/ABL1 rearrangement","volume":"37","author":"Choi","year":"2017","journal-title":"Ann Lab Med"},{"issue":"13","key":"10.1016\/j.cancergen.2019.07.004_bib0028","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/sj.onc.1203467","article-title":"The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6\/Abl) have altered substrate preferences and activate similar intracellular signalling pathways","volume":"19","author":"Voss","year":"2000","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.cancergen.2019.07.004_bib0029","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1038\/leu.2017.114","article-title":"Constitutively active ABL family kinases, TEL\/ABL and TEL\/ARG, harbor distinct leukemogenic activities in vivo","volume":"31","author":"Yokota","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.cancergen.2019.07.004_bib0030","first-page":"789","article-title":"Clonal eosinophils are a morphologic hallmark of ETV6\/ABL1 positive acute myeloid leukemia","volume":"87","author":"La Starza","year":"2002","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cancergen.2019.07.004_bib0031","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0032","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/gcc.10175","article-title":"A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene","volume":"37","author":"Murga Penas","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.cancergen.2019.07.004_bib0033","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/humu.21095","article-title":"SMC1A expression and mechanism of pathogenicity in probands with X-Linked Cornelia de Lange syndrome","volume":"30","author":"Liu","year":"2009","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.cancergen.2019.07.004_bib0034","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/emboj.2010.315","article-title":"A positively charged channel within the Smc1\/Smc3 hinge required for sister chromatid cohesion","volume":"30","author":"Kurze","year":"2011","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.cancergen.2019.07.004_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2015.123","article-title":"SIFT missense predictions for genomes","volume":"11","author":"Vaser","year":"2016","journal-title":"Nat Protocols"},{"issue":"21","key":"10.1016\/j.cancergen.2019.07.004_bib0037","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1093\/emboj\/cdf575","article-title":"Hinge-mediated dimerization of SMC protein is essential for its dynamic interaction with DNA","volume":"21","author":"Hirano","year":"2002","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.cancergen.2019.07.004_bib0038","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/ng1779","article-title":"X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations","volume":"38","author":"Musio","year":"2006","journal-title":"Nat Genet"},{"issue":"22","key":"10.1016\/j.cancergen.2019.07.004_bib0039","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cancergen.2019.07.004_bib0040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI77435","article-title":"Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes","volume":"125","author":"Yuan","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.cancergen.2019.07.004_bib0041","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/jmedgenet-2014-102573","article-title":"Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism","volume":"51","author":"Ansari","year":"2014","journal-title":"J Med Genet"},{"issue":"12","key":"10.1016\/j.cancergen.2019.07.004_bib0042","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/ajmg.a.34329","article-title":"Causes of death and autopsy findings in a large study cohort of individuals with Cornelia de Lange syndrome and review of the literature","volume":"155A","author":"Schrier","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0043","first-page":"1","article-title":"Cohesin mutations in human cancer","volume":"1866","author":"Hill","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.cancergen.2019.07.004_bib0044","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/gcc.20796","article-title":"Acute leukemias with ETV6\/ABL1 (TEL\/ABL) fusion: poor prognosis and prenatal origin","volume":"49","author":"Zuna","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.cancergen.2019.07.004_bib0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/gcc.20593","article-title":"Chronic phase of ETV6-ABL1 positive CML responds to imatinib","volume":"47","author":"Kawamata","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.cancergen.2019.07.004_bib0046","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.leukres.2012.10.021","article-title":"Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review","volume":"37","author":"Efficace","year":"2013","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.cancergen.2019.07.004_bib0047","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2141.2003.04391.x","article-title":"Clinical and genetic studies of ETV6\/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate","volume":"122","author":"Barbouti","year":"2003","journal-title":"Br J Haematol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776219301553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776219301553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:31Z","timestamp":1761896611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776219301553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":47,"alternative-id":["S2210776219301553"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2019.07.004","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}